secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001437749-25-028530
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences files 8-K with corporate presentation; no specific facts extracted
--------------------------------------------------------------------------------

- Company furnished a corporate presentation dated September 2025 as Exhibit 99.1.
- Presentation is available on the Investors section of CassavaSciences.com.
- No financial results, guidance, or business updates are disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774925028530/0001437749-25-028530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774925028530/sava20250904_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-028530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer